newsfilter
← Latest News
GlobeNewswire·

Galapagos Reports First Quarter 2026 Financial Results and Provides Business Update

Galapagos' name change to Lakefront Biotherapeutics approved at the Company's EGM ((Euronext &, NASDAQ:LKFT)Collaboration Agreement with Gilead to advance potential First and Best-in-Class T Cell Engager expected to